PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcdrAbout UsAuthor ServicesArchiveSubmitJCDR
 
J Clin Diagn Res. 2017 January; 11(1): BC05–BC08.
Published online 2017 January 1. doi:  10.7860/JCDR/2017/23846.9281
PMCID: PMC5324406

Role of Glutathione S-Transferase in Coronary Artery Disease Patients with and Without Type 2 Diabetes Mellitus

Abstract

Introduction

Glutathione S – transferase (GST) is an important enzyme in detoxification and helps in lowering oxidative stress. It is speculated that this enzyme is induced under conditions of oxidative stress as a protective mechanism.

Aim

To evaluate the status of Glutathione S–transferase in Coronary artery disease patients with and without type 2 Diabetes mellitus.

Materials and Methods

The study was conducted in the Department of Biotechnology, Swami Satyanand College of Management and Technology in collaboration with Department of Biochemistry, Govt Medical College Amritsar. A total of 133 diagnosed cases of Coronary Artery Disease (CAD) were selected from the OPD and Medicine Ward of a private hospital, Amritsar. CAD patients were segregated into two groups i.e., group-1 and group-2 on the basis if they had Type 2 Diabetes mellitus or not. A total of 110 ages and sex matched healthy individuals were taken as controls from the general population. Written informed consent was obtained from all the subjects. All the subjects were investigated for serum GST activity, Total antioxidant status, plasma GSH levels, serum MDA and lipid profile.

Results

Serum GST activity was significantly high (p<0.05) in CAD patients as compared to controls. CAD patients having Type 2 Diabetes had more raised serum GST activity, indicating marked oxidative stress in these patients. This was supported from the observation that serum MDA levels were also significantly (p<0.05) high in CAD patients with Type 2 Diabetes mellitus. Total antioxidant status was significantly depressed (p<0.05) in CAD patients whether diabetic or non-diabetic as compared to controls. No significant difference (p>0.05) in plasma GSH levels were observed between CAD patients and controls. Age and sex related variations in serum GST activity were insignificant (p>0.05)

Conclusion

Increased serum GST activity in CAD patients especially with Type 2 Diabetes is suggestive of a protective mechanism to combat increased oxidative stress which was reflected by raised serum MDA level and depressed total antioxidant status in patient group. However, whether this effect is a short term or long term, a separate follow up study is required.

Keywords: Antioxidant enzyme, Detoxication, Oxidative stress

Introduction

Oxidative stress and inflammation, aggravates and increases the risk of CAD and its associated conditions such as Type 2 Diabetes mellitus [1]. Various toxic molecules either from the external source or from the normal metabolism need to be detoxified in the body. Glutathione S –Transferase (GST) is an important enzyme which detoxifies the toxic molecules and hence lowers the oxidative stress. GST is present in cytoplasm and mitochondria of almost every cell. This enzyme belongs to a multigene family of isoenzymes that catalyze the conjugation of reduced Glutathione (GSH) to a variety of electrophilic compounds as the first step in a detoxification pathway [2]. It also detoxifies toxic metabolites produced within the cell and protects cells from oxidant injury. The redox status of glutathione is highly essential for various biological events and its homeostasis is critically regulated by GST activity. Any alteration in GSH metabolism and GST activity can affect various signaling events leading to development of different diseases [3,4]. Hence, for this reason, GST has been assumed to play an important role in various diseased conditions. Several authors tried to study the correlation of GST gene polymorphism and GST activity with various diseased conditions but the conclusions are variable. It has been shown that GSTT1/GSTM1 polymorphism was a risk factor for Type 1 Diabetes in Slovak children and adolescence [5]. Another study showed that GST activity was significantly raised in both colorectal cancer and adenomas as compared to normal colonic tissue [6] but another study reported low GST activity in colorectal cancer patients [7]. Elevated plasma GST activity has also been reported in patients with hepatocellular damage [8,9]. Other studies regarding Diabetes mellitus and metabolic disorders reported variable association of GST gene polymorphism with these diseases [10] but they have not mentioned data regarding GST activity in their studies. Chronic alcoholism is associated with increased formation of reactive oxygen species and raised GST activity was thought to be protective against alcohol intoxication [11]. GST has been reported to be a sensitive marker for the diagnosis of alcoholic liver disease [12]. All these existing reports show that GST is an important biochemical tool which could provide significant information regarding oxidative stress prevailing in several diseases.

However, very little data is available regarding the status of GST activity in Coronary artery disease. Oxidative stress plays a key role in pathogenesis of CAD. Level of oxidative stress can be assessed by Total Antioxidant Status (TAS). The total antioxidant status is an indicator of the antioxidant potential of individual antioxidant levels in cells and plasma and hence can be of higher predictive value in assessing the CAD risk. Both, increased and decreased TAS levels, have been reported in CAD patients [1315]. Antioxidant enzymes and molecules in the body give cellular protection against oxidative damage. Our main interest was to investigate the status of GST activity in Coronary artery disease. Patients with and without Type 2 Diabetes mellitus.

Materials and Methods

Present study was a case control study carried out in the Department of Biotechnology Swami Satyanand College of Management and Technology Amritsar in association with the Department of Biochemistry Government Medical College and Hospital Amritsar during the period from January 2015 to February 2016. The study comprised of diagnosed cases of CAD (n=133) and 110 age and sex matched healthy subjects as controls. All the subjects were in the age range of 30-60 years. These subjects were healthy volunteers without established complications. CAD patients were recruited from the Medicine Department of a private hospital in Amritsar. CAD patients were segregated into two groups:

Group-1 comprised of CAD patients (n=69) with Type 2 Diabetes mellitus (Fasting blood glucose>126mg/dl).

Group-2 comprised of CAD patients (n=64) without Type 2 Diabetes mellitus.

These patients (group-1) were on oral hypoglycaemic drugs but they were not on any regular antioxidant supplements. The study was approved by the institute’s ethical committee and informed consent was taken from all the subjects. A performa was designed to record the necessary details of patients as well as of controls regarding age, gender, occupation, present/past history of any disease, smoking, alcohol status and medication.

Patients with following conditions were excluded from the present study: lung disease, liver disease, renal disease, thyroid disease, habit of smoking, patients on hypolipidemic drugs and acute infections, chronic alcoholism.

Materials and Methods

A 10 ml of venous blood sample was taken from the antecubital vein of the CAD patients as well as from the apparently healthy controls, under aseptic conditions. The blood sample was divided into two halves: one in EDTA vial and another in plain vial to obtain serum. All the subjects were screened for the following biochemical investigations.

Study parameters

Serum Glutathione S-transferase assay was done using colorimetric method. Serum glutathione S-transferase activity was based upon the GST-catalyzed reaction between GSH and the GST substrate, 1-chloro-2, 4-dinitrobenzene (CDNB). The GST-catalyzed formation of GS-DNB produced a dinitrophenyl thioether which was detected by spectrophotometer at 340nm. One unit of GST activity was defined as the amount of enzyme producing 1 μmol of GS-DNB conjugate/min under the conditions of the assay. Serum Total Antioxidant Status (TAS) was assayed by procuring commercially available kit form Randox India Pvt Ltd. Briefly, 2,2 Azino-di-3-ethylbenzthiazoline sulphonae (ABTS) incubated with peroxidase (metmyoglobin) and hydrogen peroxide produced the radical cation ABTS+. This has a relatively stable blue-green color, which was measured at 600nm. Antioxidant in the added sample caused suppression of this color production to a degree which was proportional to their concentration.

GSH estimation was done in haemolysate using colorimetric method. Serum Lipid oxidation product (MDA) was estimated by the method of Beuge and Aust. Serum Lipid Profile was estimated with commercially available kit obtained from Randox Pvt., Ltd.

Statistical Analysis

The data were analysed by SPSS 16.0 software. Data were expressed as mean±SD standard deviation. The difference between the groups and sub groups were interpreted using student (t) test. A p-value less than 0.05 were considered statistically significant.

Results

Serum GST activity was significantly raised (p<0.05) in CAD patients as compared to controls [Table/Fig-1]. Age and sex related variations in serum GST activity were insignificant (p>0.05; data not shown). As mentioned earlier, CAD patients were classified into two Groups: group-1 and group-2. Serum GST activity was significantly raised (p<0.05) in group-1 CAD patients i.e., with Type 2 Diabetes mellitus as compared to CAD patients in group-2 and controls [Table/Fig-2]. This clearly indicated the presence of marked oxidative stress in these patients. This was further supported from the observation that serum MDA levels were significantly high (p<0.05) in group-1 CAD patients [Table/Fig-3]. However, no significant variations (p>0.05) in plasma GSH levels were observed in this respect [Table/Fig-3].

[Table/Fig-1]:
Serum GST activity (IU/L) in CAD patients as compared to controls.
[Table/Fig-2]:
Serum GST activity in CAD patients with and without Type 2 Diabetes mellitus in comparison to controls.
[Table/Fig-3]:
Serum MDA and plasma GSH levels in CAD patients with and without type 2 diabetes mellitus in comparison to controls.

We were interested to evaluate the Total Antioxidant Status (TAS) of CAD patients with and without Type 2 Diabetes mellitus since plasma GSH levels did not show any significant variations. TAS was studied with the help of commercially available kit. TAS was highly depressed (p<0.05) in CAD patients (both group1 and 2) as compared to controls [Table/Fig-4].

[Table/Fig-4]:
Serum Total antioxidant status in CAD patients with and without type 2 Diabetes mellitus in comparison to controls.

Serum lipid and lipoprotein cholesterol levels of patients and controls were also compared [Table/Fig-5] since this has been a routine investigation and needs to be checked. However, among all parameters, only serum triglyceride levels were observed to be significantly increased (p<0.05) in group-1 CAD patients as compared to controls. All other parameters did not show any significant variations (p>0.05).

[Table/Fig-5]:
Comparative account of serum lipid levels of CAD patients (Group 1 and Group 2) and controls.

Discussion

The role of oxidative stress has been established in coronary artery disease. GST is an important enzyme consisting of 3 supergene families; cystosolic, mitochondrial and membrane bound microsomal proteins which are involved in phase II detoxification of endogenous compounds and xenobiotics [16]. GST catalyzes the conjugation of reduced form of glutathione (GSH) to xenobiotics substrate for the purpose of detoxification [17].

We observed significantly increased serum GST activity in CAD patients as compared to controls, activity being more raised in CAD patients with Type 2 Diabetes mellitus. It could be possible that GST activity may be induced to combat the increased oxidative stress and hence can be speculated as a protective mechanism. GST works by conjugating GSH with several toxic molecules in order to detoxify them and facilitates their excretion. Hence, we were interested to evaluate the levels of GSH in this respect. However, insignificant difference was observed in plasma GSH levels between group-1 and group-2 CAD patients and controls. This indicates that it may be possible that GST activity and GSH do not bare any proportionate relationship and hence levels can vary. There was no significant correlation (p>0.05) observed between serum GST activity and plasma GSH levels. group-1 patients had an increased oxidative stress as reflected by the raised serum MDA levels, which is a by-product of auto-oxidation of polyunsaturated fatty acids [18].

Evaluation of Total Antioxidant Status (TAS) of CAD patients was highly important. TAS was assayed with commercially procured kit. Total antioxidant status was markedly low in CAD patients as compared to controls which further indicate increased oxidative stress in CAD patients. Other studies also reported low plasma TAS levels in patients suffering from coronary artery disease [14,15].

Oxidative stress is highly involved in the pathogenesis of CAD [19,20]. This information was not gained from GSH levels. Significantly increased serum GST activity in CAD patients especially with Type 2 Diabetes mellitus, increased MDA and low Total Antioxidant Status (TAS) is suggestive of increased oxidative stress prevailing with hyperglycaemia which could further enhance the process of atherosclerosis in CAD. Raised GST activity has been reported in Type 2 Diabetes patients as compared to healthy controls [21]. As far as the CAD is concerned, the existing studies mainly reported the association of GST polymorphism with coronary artery disease but did not mention the status of GST activity which may be affected by the GST polymorphism [22,23]. In the present study we evaluated GST activity. However, the GST polymorphism could give a better picture regarding its role in CAD and Type 2 Diabetes mellitus. Our results support the use of GST as an informative biochemical marker for the evaluation of oxidative stress in coronary artery disease and associated conditions like Type 2 Diabetes mellitus.

Limitation

We have not done the follow-up study which could be more informative evaluating the role of induced GST activity as a protective mechanism against oxidative stress. Moreover, evaluation of GST activity with GST gene polymorphism may provide additional information in CAD. We are planning to conduct study on GST gene polymorphism in our population.

Conclusion

Serum GST has been observed to be an informative marker of the prevailing oxidative stress in CAD patients with and without Type 2 Diabetes mellitus. Increased serum GST activity is a protective mechanism to combat increased oxidative stress.

Acknowledgments

We are highly thankful to all the subjects who participated in this study. Our sincere thanks to Dr H.P Singh, Cardiologist, Fortis Hospital, Amritsar for providing support in recruiting the patients. Help provided by Mr. Rajneesh, lab manager, is highly acknowledged.

Notes

Financial or Other Competing Interests

None.

References

[1] Keenan Y, Razz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, et al. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci. 2015;16:25234–63. [PMC free article] [PubMed]
[2] Gontil N, Kadioglu E. The role of GSTM1, GSTT1, GSTP1 and OGG1 polymorphism in type 2 diabetes mellitus risk: A case-control study in a Turkish population. Gene. 2012;505:121–27. [PubMed]
[3] Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutahione metabolism and its implications for health. J Nutr. 2004;134:489–92. [PubMed]
[4] Sen CK. Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul. 2000;36:1–30. [PubMed]
[5] Vojtkova J, Durdik PM, Ciljakova M, Michnova Z. The association between gene polymorphisms of glutathione’s transferase T1/M1 and Type 1 Diabetes in Slovak children and adolescents. Cent Eur J Public Health. 2013;21:88–91. [PubMed]
[6] Naidu KA, Nasir A, Pinkas H, Kaiser HE, Brady P. Glutathione S-transferasepi expression and activity is increased in colonic neoplasia. In Vivo. 2003;17:479–82. [PubMed]
[7] Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, et al. Glutathione S-tra nsferase activity and Glutathione S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res. 1995;55:2789–93. [PubMed]
[8] Mulder TPJ, Court DA, Peters WHM. Variability of Glutathione S-transferase α in human liver and plasma. Clin Chem. 1999;45:355–59. [PubMed]
[9] Beckett GJ, Hayes JD. Gluthione S-transferase: biomedical applications. Clin Chem. 1993;30:281–380. [PubMed]
[10] Santl LM, Letonja M, Ikolajevic-Starcevic JN, Petrovic D. Association of manganese superoxide dismutase and gliutathione S-transferase genotypes with carotid atherosclerosis in patients with diabetes mellitus 2. Int Angiol. 2012;31:33–41. [PubMed]
[11] Gutavicz M, Kazmierczak B, Baranczyk-Kuzma A. The influence of heroin abuse on glutathione dependent enzymes in human brain. Drug Alcohol Edpend. 2011;113:8–12. [PubMed]
[12] Singh M, Aggaewal HK, Aggarwal SK. Significance of glutathione S- transferase activity and total thiol status in chronic alcoholism. JCDR. 2012;3601:1859.
[13] Aydin M, Selcoki Y, Nazli Y, Colak N, Yalcin KS, Canbal M, et al. Relationship between total antioxidant capacity and the severity of coronary artery. J Clin Exp Invest. 2012;3:22–28.
[14] Shaikh AK, Suryakar AN. Oxidative stress and antioxidant status before and after supplementation of A-Z antioxidant tablets in coronary artery disease. Biom Res. 2009;20:136–40.
[15] Fazendus P, Joao IF, Liobet S. Plasma total antioxidant status in young survivors of myocardial infarction. Rev Port Card. 2000;19:463–67. [PubMed]
[16] Raza H. Dual Localization of glutathione s transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease. FEBS J. 2011;278:4243–51. [PMC free article] [PubMed]
[17] Leaver MJ, George SG, piscine A. Glutathione-s – transferase which efficiently conjugates the end product of lipid peroxidation. Mar Environ Res. 1998;46:71–74.
[18] Kaur K, Bedi G, Kaur M, Vij A, Kaur I. Lipid peroxidation and level of antioxidant enzymes in coronary artery disese. Indian J Clin Biochem. 2008;23:33–37. [PMC free article] [PubMed]
[19] Yegin A, Yegin H, Aliciguzel Y. Erythrocyte Selenium glutathione peroxidase activity is lower in patients with coronary atherosclerosis. Jpn Heart Jr. 1997;38:793–79. [PubMed]
[20] Bhat MK, Mahajan N, Gandhi G. Oxidative stress status in coronary artery disease patients. Int. J Life Sc Bt and Pharma Res. 2012;2:2250–3137.
[21] Sharma M, Gupta S, Singh K, Mehndiratta M, Gautam A, Kalra O, et al. Association of glutathione S-transferase with patients of type 2 diabetes mellitus with and without nephropathy. Diabetes Metab Syndr. 2016;10:194–97. [PubMed]
[22] Kim S J, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. Impact of glutathione S-transferase M1and T1 gene polymorphism on the smoking related coronary artery disease. J KoreanMed Sci. 2008;23:365–72. [PMC free article] [PubMed]
[23] Wang J, Zou LJ, Huang SD, Lu FL, Lang XL, Han L, et al. Genetic polymorphism of glutathione S- transferase genes GSTM, GSTT and risk of coronary heart disease. Mutagenesis. 2010;25:365–69. [PubMed]

Articles from Journal of Clinical and Diagnostic Research : JCDR are provided here courtesy of JCDR Research & Publications Private Limited